Germline pathogenic variants in these three genes are associated with a greater than 8-fold odds of TNBC relative to women with sporadic breast cancer [17, 19, 20], although among BRCA2 and PALB2 carriers, ER + HER2- breast cancer is still the most common biologic subtype. Here, ESR1 is linked to breast carcinoma.